Successful treatment of synovitis, acne, pustulosis, hyperostosis and osteitis syndrome with ixekizumab.

Abstract

We report the use of ixekizumab in treating synovitis, acne, pustulosis, hyperostosis and osteitis (SAPHO) syndrome, the first such report to our knowledge. The patient presented with palmoplantar pustulosis and sternoclavicular joint pain, which was markedly improved with ixekizumab treatment.

• Authors: RuiYuan Xia, ZiYue Diao, ZhiQin Zhang, Jian Liu, ZhiQiang Yin
• Journal: Clinical and experimental dermatology (Clin Exp Dermatol) Vol. 47 Issue 5 Pg. 978-980 (May 2022) ISSN: 1365-2230 [Electronic] England
• PMID: 35089610 (Publication Type: Letter)
• Copyright: © 2022 British Association of Dermatologists.

Chemical References

• Antibodies, Monoclonal, Humanized
• ixekizumab

Topics

• Acne Vulgaris (drug therapy)
• Acquired Hyperostosis Syndrome (diagnosis, drug therapy)
• Antibodies, Monoclonal, Humanized
• Humans
• Hyperostosis
• Osteitis (diagnosis, drug therapy)
• Synovitis (drug therapy)